NEW YORK, Sept. 1 /PRNewswire-USNewswire/ -- The 10th International Conference on Alzheimer’s Drug Discovery, hosted by the Alzheimer’s Drug Discovery Foundation and the only scientific conference focusing solely on the discovery and development of innovative drugs targeting Alzheimer’s disease and related dementias, will convene September 14-15, 2009 at the Hyatt Regency in Jersey City, N.J.
More than 30 leading international experts from academia and early-stage biotechnology companies will present and discuss their most current research. The meeting draws an audience of academic and industry scientists engaged in drug discovery research for neurodegenerative diseases. Because of ADDF’s venture philanthropy focus, the conference is also open to business development and licensing professionals, alliance management professionals, venture capitalists, and other investors in biotechnology.
The conference program will focus on four major areas of study:
Anti-Amyloid and Protein Misfolding
Chair: Michael Wolfe, PhD, Brigham and Women’s Hospital
Alternative Strategies: New Targets for Alzheimer’s Disease Therapy
Chair: Diana Shineman, PhD, Alzheimer’s Drug Discovery Foundation
The Alzheimer’s Drug Discovery Foundation will also present the 2009 ADDF Young Investigators Scholarships, highly prestigious scholarships recognizing the early research achievements of ten younger scientists from academia.
For Conference Participants: To view the complete program schedule, to apply to register for the conference, and for information on accommodations, visit www.alzdiscovery.org.
SOURCE Alzheimer’s Drug Discovery Foundation
CONTACT: Filomena Machleder of Alzheimer’s Drug Discovery Foundation,
+1-212-901-8004
Web site: http://www.alzdiscovery.org/
